Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of lariatin a in China, also supports custom service. Welcome to wholesale bulk high quality lariatin a from our factory. Contact us for more details.
| Description | Lynronne-1 is a cationic antimicrobial peptide identified from bovine rumen microbiome metagenomic fosmid clones, with the sequence Leu-Pro-Arg-Arg-Asn-Arg-Trp-Ser-Lys-Ile-Trp-Lys-Lys-Val-Val-Thr-Val-Phe-Ser-NH₂ (one-letter: LPRRNRWSKIWKKVVTVFS-NH2), C-terminally amidated, totaling 19 amino acid residues, with a theoretical molecular weight of 2399.88 Da and molecular formula C₁₁₃H₁₈₃N₃₅O₂₃. Lynronne-1 belongs to the Lynronne antimicrobial peptide family (including Lynronne-1, -2 and -3), a novel class of natural antimicrobial peptides discovered from the rumen microbiome, originating from fosmid clone SABPL29H11. The sequence contains 6 cationic residues (4 arginines and 2 lysines) and adopts an alpha-helical conformation in solution, containing a 13-residue amphipathic helix that carries all six cationic residues. Lynronne-1 exhibits broad-spectrum antimicrobial activity against common Gram-positive and Gram-negative pathogenic bacteria, including methicillin-resistant Staphylococcus aureus (MRSA, MIC 8-32 μg/mL), Pseudomonas aeruginosa (MIC 16-64 μg/mL), and Acinetobacter baumannii (MIC 2-128 μg/mL), along with anti-biofilm activity. The antimicrobial mechanism of Lynronne-1 primarily involves membrane lysis: as a cationic amphipathic alpha-helical peptide, Lynronne-1 interacts electrostatically with negatively charged anionic lipids on the bacterial cell membrane surface through its positively charged arginine and lysine residues, after which the amphipathic helix selectively inserts into the membrane lipid bilayer and causes membrane lysis, with selectivity toward anionic-lipid-containing membranes. Due to its unique mechanism of action and low propensity for inducing resistance, Lynronne-1 is an important candidate for novel antibacterial drug development. Lynronne-1 is widely used in novel antibiotic development (especially against drug-resistant bacteria such as MRSA and A. baumannii), microbiome antimicrobial peptide mining, anti-biofilm research, antimicrobial peptide structure-activity relationship research, and drug-resistant infection treatment research. |
| Molecular formula | C₁₁₃H₁₈₃N₃₅O₂₃ |
| Molecular weight (Da) | 2399.88 |
| Structure type | Linear 19-mer peptide (C-terminally amidated, rumen microbiome-derived cationic amphipathic alpha-helical antimicrobial peptide, containing 4 arginines and 2 lysines, membrane-lytic mechanism, anti-MRSA) |
| Solubility | Freely soluble in water, PBS, DMSO |
| Storage | -20°C, dry, protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| Lariatin A | Lariatin A; anti-tuberculosis lanthipeptide | Anti-tuberculosis peptide, Gram-positive targeting, cell wall synthesis inhibition, natural antibiotic, anti-mycobacterial | Lanthionine-containing cyclic peptide antibiotic produced by actinomycetes, forming a rigid cyclic conformation via lanthionine thioether bonds; specifically targets MraY, a key enzyme in bacterial cell wall synthesis, inhibits peptidoglycan synthesis, and has potent inhibitory effects on Mycobacterium tuberculosis including multidrug-resistant strains | C₈₄H₁₃₁N₂₇O₁₉S | 1886.99 | ~1888.4 | Free peptide | 18 (cyclic peptide) |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-LARIA | White powder | Store at -20°C, sealed, dry and protected from light, under inert gas. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; protect from oxygen during shipping. | Stable for 7 days at 4°C. Soluble in dilute acetic acid, acidic buffers and methanol. Thioether bond is sensitive to strong oxidants; cyclic conformation is pH-stable. Avoid co-incubation with strong oxidizing reagents. | Stable for 2 years at -20°C, dry, protected from light and under inert gas. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-LARIA | Anti-tuberculosis Lariatin A targeting cell wall synthesis against mycobacteria | Lariatin A is a lanthipeptide antibiotic from actinomycetes, rigidified by lanthionine thioether bonds with far higher stability than linear peptides. It specifically targets MraY, a key enzyme in bacterial cell wall synthesis, blocks peptidoglycan precursor translocation and polymerization, and inhibits cell wall synthesis leading to lysis, potent against M. tuberculosis including MDR strains. | Anti-tuberculosis drug development, mycobacterial infections, cell wall synthesis mechanism, lanthipeptides, natural product antibiotics | Bacterial cell wall synthase MraY; peptidoglycan synthesis inhibition; thioether-stabilized cyclic conformation |
Hot Tags: lariatin a, China lariatin a manufacturers, suppliers, factory, 143459-88-5, 188713-80-6, 79404-91-4, antimicrobial peptides, CAS 79404 91 4, CP7-FP13-2
